Flavopiridol enhances the effect of docetaxel in vitro and in vivo in human gastric cancer cells.

Abstract

Gastric cancer is one of the leading causes of cancer death throughout the world. It is a disease in desperate need of new therapeutic approaches. Docetaxel, a semisynthetic taxane, has shown potent activity against a broad range of solid tumors. However, in gastric cancer, response rates to docetaxel remain only approximately 20%. In these studies we show… (More)

Topics

Cite this paper

@article{Motwani2003FlavopiridolET, title={Flavopiridol enhances the effect of docetaxel in vitro and in vivo in human gastric cancer cells.}, author={Monica Motwani and Carina Rizzo and Francis M. Sirotnak and Yuhong She and Gary K. Schwartz}, journal={Molecular cancer therapeutics}, year={2003}, volume={2 6}, pages={549-55} }